Follow Up Q&A With Dr. Murrough – The Role Of Glutamate In Mood Disorders & Schizophrenia
During this question and answer session, Dr. James Murrough responds to unanswered questions from the PsychU webinar, “The Role of Glutamate in Mood Disorders & Schizophrenia,” which took place on March 19, 2019.
James Murrough, M.D., Ph.D., is an Associate Professor of Psychiatry and Neuroscience, and the Director of the Depression & Anxiety Center for Discovery & Treatment at the Icahn School of Medicine at Mount Sinai. He conducts clinical and translational research aimed at understanding the biological basis of mood …
Disclaimer: PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI). Specific PsychU programs may be supported by OPDC, OAPI and other committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsor or the sponsors of the specific PsychU program in which such opinions are expressed. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC and OAPI.